Author

A. Bertolini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Fedier· 1 shared A. W. Graf· 1 shared B. Bodenmiller· 1 shared B. Seashore-Ludlow· 1 shared C. Kurzeder· 1 shared C. Montavon Sartorius· 1 shared C. Rempfer· 1 shared E. L. Decker· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Fedier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases

C. Rempfer, S. N. W. Hoernstein, N. van Gessel, A. W. Graf, R. P. Spiegelhalder, A. Bertolini, L. L. Bohlender, J. Parsons, E. L. Decker, R. Reski

This study identifies six prolyl-4 hydroxylases in mosses and characterizes their substrate specificity, structural features, and functional roles in proline hydroxylation and O-glycosylation.

bioRxiv · Mar 26, 2024Plant Biology

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis

R. Coelho, B. Seashore-Ludlow, S. Schutz, F. Christopher Lombardo, E. Moussaud-Lamodiere, R. Casanova, J. Ficek-Pascual, K. Brunhilde Labrosse, M. Hensle, M. Lopez-Nunez, N. Rimmer, A. Fedier, R. Lima, C. Montavon Sartorius, C. Kurzeder, , F. Jacob

This study shows SMAC mimetics overcome apoptotic resistance in ovarian cancer by targeting the MSLN-TNF alpha axis, enhancing cell death and synergizing with chemotherapy.

bioRxiv · Jan 24, 2024 · PreprintCancer Biology